CenterWatch Webinar Training Pass

Gain Access to Dozens of Web-Based Training Programs For One Low Price!

We can't provide you with more staff members or travel money to get to new training programs. But we can provide expert training for you in ONE place...without ever leaving your office. The Webinar Training Pass gives you year-round unrestricted access to dozens of on-demand training webinars, featuring top clinical trials experts and FDA officials. Need training on a topic? The Training Pass lets you train on your schedule—on the subjects you need most. Webinar Training Pass Gives You:

  1. Training from the best minds and thought leaders in the clinical trials industry.
  2. Wide variety of topics to help you stay in compliance with the FDA.
  3. Instant, on-demand, unlimited access to dozens of archived webinars.
  4. One automatic registration to more than 40 live webinars we'll host during the life of your subscription.

Single-User, One-Year Unlimited Webinar Access for only $597

Don't forget this includes all our archives, PLUS all the new webinars we produce for 12 months, all available on YOUR SCHEDULE!

Purchase 1-year Access

Note: After purchase, you access will be emailed to you within one business day from date of purchase. If you have not received your login information, please contact customer service.

Want training for your entire team? Call (888) 838-5578 or email customerservice@fdanews.com for multi-user pricing to receive deep discounts for 2, 5 or even unlimited users.

Login

Registered User? Login Now

Forgot Your Password? Recover it

Managing Combination Product Safety Reporting

57 minutes

Recorded on Wednesday, January 31, 2018

Description

Combination products expert Angela Pitwood interprets the FDA’s final rule on post-approval safety and reporting for combination products. She discusses:

  • Who on the product safety staff should have the responsibility for combination product safety and reporting;
  • How to avoid receiving FDA warning letters on combination product reporting and safety; and
  • How to implement real-world best practices for safety reporting.

Speaker: Angela Pitwood, Vice President of Pharmacovigilance, Vigilare

Strategies that Inform Investigator Selection and Enhance Enrollment

60 minutes

Recorded on Thursday, January 25, 2018

Description

Clinical trial contracting experts Suzanne Caruso and Brooke Millman discuss negotiating and finalizing site contracts to ensure that you begin your next study holding all the cards: quick startup, decreased costs, no unnecessary terms and conditions that cause hassles and delays. They cover:

  • Start-up dates, deadlines, and schedules;
  • Necessary and avoidable costs and expenses;
  • Air-tight provisions that avoid hassles and complications
  • Enrolling patients to expedite trials and time to market; and
  • Payment terms and conditions that meet your budget.

Speakers: Suzanne Caruso, Vice President , Clinical Solutions, and Brooke Millman, Vice President, Consulting Solutions, WIRB Copernicus Group

Sensors and Wearables in Clinical Trials

88 minutes

Recorded on Wednesday, December 20, 2017

Description

Device expert Thomas Shook discusses how the use of wearable devices and sensors can impact the world of clinical trials. He covers:

  • Best practices in use of sensors and wearables, including subject protection and data privacy;
  • How mHealth is changing data collection in clinical trials;
  • New types of health information now collectible with sensors; and
  • The regulatory impact of sensors and wearables.

Speaker: Thomas Shook, Executive Vice President and Senior Medical Officer, PAREXEL

Managing FDA GCP/Bioresearch Monitoring Inspections

68 minutes

Recorded on Tuesday, October 31, 2017

Description

Regulatory expert David Rosen discusses how principal investigators and sponsors can develop a strategy for dealing with FDA inspections. He covers:

  • How BIMO inspections are started and conducted;
  • What the BIMO team is looking for in terms of following proper protocols for patient recruitment;
  • FDA-recommended best practices in execution of consent forms; and
  • Whether patient volunteers are actually eligible participants in a clinical trial.

Speaker: David Rosen, Partner, Foley & Lardner LLP